| cellular response to menadione |
| deadenylation-dependent decapping of nuclear-transcribed mRNA |
| m7G(5)pppN diphosphatase activity |
| RNA 7-methylguanosine cap binding |
| exoribonuclease activity |
| mRNA cis splicing, via spliceosome |
| exonucleolytic catabolism of deadenylated mRNA |
| nuclear-transcribed mRNA catabolic process, exonucleolytic |
| RNA phosphodiester bond hydrolysis, exonucleolytic |
| nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| P-body |
| cellular response to ketone |
| RNA phosphodiester bond hydrolysis |
| response to ketone |
| nuclear-transcribed mRNA catabolic process |
| mRNA catabolic process |
| RNA catabolic process |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| mRNA splicing, via spliceosome |
| nucleic acid phosphodiester bond hydrolysis |
| RNA splicing, via transesterification reactions |
| nucleobase-containing compound catabolic process |
| RNA splicing |
| cellular response to drug |
| heterocycle catabolic process |
| cellular nitrogen compound catabolic process |
| aromatic compound catabolic process |
| mRNA processing |
| organic cyclic compound catabolic process |
| mRNA metabolic process |
| RNA processing |
| cellular macromolecule catabolic process |
| negative regulation of programmed cell death |
| negative regulation of cell death |
| response to drug |
| macromolecule catabolic process |
| cellular response to oxygen-containing compound |
| mitochondrion |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| RNA metabolic process |
| regulation of cell death |
| negative regulation of gene expression |
| organic substance catabolic process |
| cellular catabolic process |
| gene expression |